#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17522	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2110	820.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1678	1678	T	958	T,C	912,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17522	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2110	820.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	979	C	953	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3572	907.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1669	1669	A	1022	A	1006	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3572	907.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2303	2303	C	1024	C	997	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3572	907.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2377	2377	A	1012	A	990	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3572	907.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2929	2929	C	1006	C,A	980,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32688	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3572	907.1	0	HET	.	.	.	C2847T	.	2847	2847	C	3179	3179	C	990	C,T	770,194	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	50184	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1568	3173.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2424	folP	855	855	99.88	folP.l15.c4.ctg.1	1487	161.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1037	1039	AGC	216;216;218	A;G;C	211;209;208	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	6868	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3499	194.8	0	.	p	.	0	D95A	NONSYN	283	285	GAC	683	685	GCC	237;235;233	G;C;C	234;233;231	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	6868	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3499	194.8	1	SNP	p	S91F	1	.	.	271	273	TTC	671	673	TTC	247;250;247	T;T;C	243;246;242	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	2002	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1435	138.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	502	504	ACC	236;239;236	A,G;C;C	226,1;228;227	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	2002	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1435	138.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	700	702	CAC	258;261;261	C,T;A;C	252,1;250;251	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	2002	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1435	138.6	0	.	p	.	0	A127fs	FSHIFT	379	379	G	766	766	G	238	G	228	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	2002	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1435	138.6	1	SNP	p	G45D	0	.	.	133	135	GGC	520	522	GGC	220;217;213	G,T;G;C	218,1;216;213	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1078	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	987	108.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5946	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2839	207.2	0	.	p	.	0	S87N	NONSYN	259	261	AGT	536	538	AAT	223;224;227	A;A;T	219;220;223	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5946	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2839	207.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1580	1582	GCA	213;213;213	G;C,G;A	203;186,1;197	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5946	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2839	207.2	1	SNP	p	D86N	0	.	.	256	258	GAC	533	535	GAC	224;222;225	G;A;C	220;215;219	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5946	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2839	207.2	1	SNP	p	S88P	0	.	.	262	264	TCC	539	541	TCC	224;224;220	T;C;C	221;218;212	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4950	parE	1986	1986	99.95	parE.l6.c4.ctg.1	2549	192.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1502	1504	GGC	224;225;226	G;G;C	218;220;220	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1306	1308	GCA	267;270;271	G;C;A	259;257;264	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1309	1311	ATC	277;277;271	A;T;C	270;269;264	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1321	1323	GTG	275;278;282	G;T;G	270;272;278	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1321	1323	GTG	275;278;282	G;T;G	270;272;278	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1825	1827	ACC	207;208;208	A;C;C	196;199;202	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1879	1881	GCG	206;202;204	G;C,G;G	194;178,5;189	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1879	1881	GCG	206;202;204	G;C,G;G	194;178,5;189	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2002	2004	GGT	188;186;185	G;G;T	182;182;178	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2011	2013	GGC	189;187;187	G;G;C	182;178;176	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4842	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2461	194.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2029	2031	CCG	151;152;146	C,G;C;G	121,2;126;124	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6922	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	2940	232.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1546	1548	CCG	252;254;251	C,T;C;G,C	234,1;248;238,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3226	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1764	180.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	518	518	C	241	C,G	227,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	283	285	GAA	240;237;237	G;A;A	233;231;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	D121G	NONSYN	361	363	GAC	532	534	GGC	257;256;255	G;G;C,T	250;249;247,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	694	696	TCA	274;275;274	T,A;C;A	269,1;273;274	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	730	732	CAA	283;285;287	C;A;A	273;277;281	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	G189S	NONSYN	565	567	GGC	736	738	AGC	295;294;295	A;G;C	285;285;286	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	F215T	NONSYN	643	645	TTT	814	816	ACT	307;306;308	A;C;T	300;297;301	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	823	825	GTG	306;303;302	G,A;T,G;G,C	300,1;290,2;292,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	A242V	NONSYN	724	726	GCC	895	897	GTT	282;282;279	G;T;T,C	273;271;271,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	0	.	p	.	0	V293A	NONSYN	877	879	GTT	1048	1050	GCT	272;274;273	G;C;T	266;269;267	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3318	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1360	239.3	1	SNP	p	G120K	1	.	.	358	360	AAG	529	531	AAG	255;254;257	A;A;G,T	248;249;250,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11888	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4926	239.3	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2087	2089	AAT	280;285;280	A;A;TAAA,TAA	272;276;267,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1306	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	911	141.1	1	SNP	p	V57M	1	.	.	169	171	ATG	412	414	ATG	258;258;256	A;T;G	252;251;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	956	958	ACG	338;336;332	A;C;G	332;331;328	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	977	979	GAC	325;323;326	G;A;C	322;318;325	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	T190M	NONSYN	568	570	ACG	995	997	ATG	326;325;321	A;T;G	325;325;320	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1007	1009	TCA	324;328;329	T;C;A	319;327;329	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1052	1054	CAG	374;374;375	C;A;G	373;374;375	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1073	1075	CTT	343;336;333	C;T;T	343;333;331	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1094	1096	AGT	321;321;325	A;G;T,A	317;315;315,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1163	1165	CCG	382;383;390	C,A;C;G	377,1;380;386	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1265	1267	TCG	377;378;381	T;C;G	369;368;368	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1436	1438	AAA	248;249;242	A;A;A	245;245;237	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1439	1441	AAG	240;232;232	A;A;G	236;230;229	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1454	1456	CAC	210;210;209	C;A;C,T	209;201;207,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1493	1495	GAA	214;214;216	G;A;A	214;213;214	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1571	1573	ACG	150;149;144	A;C;G,T	148;149;142,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1622	1624	ATT	180;180;179	A;T;T	174;175;174	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1625	1627	AGT	181;182;183	A;G;T	175;177;172	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1664	1666	CTA	224;222;225	C,A;T;A	218,1;219;221	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1706	1708	AAT	167;166;167	A;A;T	165;165;166	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1775	1777	TCA	247;250;254	T;C;A	245;245;244	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1799	1801	ATG	264;263;265	A,G;T;G	260,1;262;263	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2093	2095	ACC	448;446;447	A;C,T;C	435;435,1;438	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8616	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2653	322.4	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2189	2191	GAA	469;468;465	G;A;A	457;461;459	.	Tetracycline resistance
